Literature DB >> 31871251

Pilot Trials in Nephrology: Establishing a BASE for Large-Scale Randomized Trials.

Brendon L Neuen1, Vlado Perkovic2,3.   

Abstract

Keywords:  chronic kidney disease; clinical trial; randomized controlled trials

Mesh：

Substances：

Year:  2019        PMID： 31871251      PMCID： PMC6934990          DOI： 10.1681/ASN.2019111196

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  13 in total

Review 1.  The number, quality, and coverage of randomized controlled trials in nephrology.

Authors:  Giovanni F M Strippoli; Jonathan C Craig; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

Review 2.  Action plan for optimizing the design of clinical trials in chronic kidney disease.

Authors:  Vlado Perkovic; Jonathan C Craig; Worawon Chailimpamontree; Caroline S Fox; Guillermo Garcia-Garcia; Mohammed Benghanem Gharbi; Meg J Jardine; Ikechi G Okpechi; Neesh Pannu; Benedicte Stengel; Katherine R Tuttle; Katrin Uhlig; Andrew S Levey
Journal:  Kidney Int Suppl (2011)       Date:  2017-09-20

3.  Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

Authors:  Andrew S Levey; Ron T Gansevoort; Josef Coresh; Lesley A Inker; Hiddo L Heerspink; Morgan E Grams; Tom Greene; Hocine Tighiouart; Kunihiro Matsushita; Shoshana H Ballew; Yingying Sang; Edward Vonesh; Jian Ying; Tom Manley; Dick de Zeeuw; Kai-Uwe Eckardt; Adeera Levin; Vlado Perkovic; Luxia Zhang; Kerry Willis
Journal:  Am J Kidney Dis       Date:  2019-08-28       Impact factor: 8.860

4.  The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial.

Authors:  Matthew A Roberts; Helen L Pilmore; Francesco L Ierino; Sunil V Badve; Alan Cass; Amit X Garg; Nicole M Isbel; Henry Krum; Elaine M Pascoe; Vlado Perkovic; Anish Scaria; Andrew M Tonkin; Liza A Vergara; Carmel M Hawley
Journal:  Am J Kidney Dis       Date:  2015-12-22       Impact factor: 8.860

5.  The Safety of Eplerenone in Hemodialysis Patients: A Noninferiority Randomized Controlled Trial.

Authors:  Michael Walsh; Braden Manns; Amit X Garg; Joe Bueti; Christian Rabbat; Andrew Smyth; Jessica Tyrwhitt; Jackie Bosch; Peggy Gao; P J Devereaux; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

Review 6.  Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.

Authors:  Adeera Levin; Marcello Tonelli; Joseph Bonventre; Josef Coresh; Jo-Ann Donner; Agnes B Fogo; Caroline S Fox; Ron T Gansevoort; Hiddo J L Heerspink; Meg Jardine; Bertram Kasiske; Anna Köttgen; Matthias Kretzler; Andrew S Levey; Valerie A Luyckx; Ravindra Mehta; Orson Moe; Gregorio Obrador; Neesh Pannu; Chirag R Parikh; Vlado Perkovic; Carol Pollock; Peter Stenvinkel; Katherine R Tuttle; David C Wheeler; Kai-Uwe Eckardt
Journal:  Lancet       Date:  2017-04-20       Impact factor: 79.321

7.  The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.

Authors:  Dick de Zeeuw; Blai Coll; Dennis Andress; John J Brennan; Hui Tang; Mark Houser; Ricardo Correa-Rotter; Donald Kohan; Hiddo J Lambers Heerspink; Hirofumi Makino; Vlado Perkovic; Yili Pritchett; Giuseppe Remuzzi; Sheldon W Tobe; Robert Toto; Giancarlo Viberti; Hans-Henrik Parving
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

8.  Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Authors:  Allison Tong; Braden Manns; Angela Yee Moon Wang; Brenda Hemmelgarn; David C Wheeler; John Gill; Peter Tugwell; Robert Pecoits-Filho; Sally Crowe; Tess Harris; Wim Van Biesen; Wolfgang C Winkelmayer; Adeera Levin; Aliza Thompson; Vlado Perkovic; Angela Ju; Talia Gutman; Amelie Bernier-Jean; Andrea K Viecelli; Emma O'Lone; Jenny Shen; Michelle A Josephson; Yeoungjee Cho; David W Johnson; Bénédicte Sautenet; Marcello Tonelli; Jonathan C Craig
Journal:  Kidney Int       Date:  2018-10-22       Impact factor: 10.612

9.  Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Colin Baigent; William G Herrington; Josef Coresh; Martin J Landray; Adeera Levin; Vlado Perkovic; Marc A Pfeffer; Peter Rossing; Michael Walsh; Christoph Wanner; David C Wheeler; Wolfgang C Winkelmayer; John J V McMurray
Journal:  Kidney Int       Date:  2017-08       Impact factor: 10.612

Review 10.  Kidney disease trials for the 21st century: innovations in design and conduct.

Authors:  William G Herrington; Natalie Staplin; Richard Haynes
Journal:  Nat Rev Nephrol       Date:  2019-10-31       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.